S&P 500   4,109.31
DOW   33,274.15
QQQ   320.93
MarketBeat Week in Review – 3/27 - 3/31
Modern Day Options Trading For Beginners! (Ad)pixel
UK travelers face hours-long waits for ferries to France
Intensity and insults rise as lawmakers debate debt ceiling
Modern Day Options Trading For Beginners! (Ad)pixel
Credit Suisse takeover hits heart of Swiss banking, identity
Small areas reopen near Fukushima nuclear plant, few return
Did You See These Trend Reversals? (Ad)pixel
UN food chief: Billions needed to avert unrest, starvation
'War of the states': EV, chip makers lavished with subsidies
S&P 500   4,109.31
DOW   33,274.15
QQQ   320.93
MarketBeat Week in Review – 3/27 - 3/31
Modern Day Options Trading For Beginners! (Ad)pixel
UK travelers face hours-long waits for ferries to France
Intensity and insults rise as lawmakers debate debt ceiling
Modern Day Options Trading For Beginners! (Ad)pixel
Credit Suisse takeover hits heart of Swiss banking, identity
Small areas reopen near Fukushima nuclear plant, few return
Did You See These Trend Reversals? (Ad)pixel
UN food chief: Billions needed to avert unrest, starvation
'War of the states': EV, chip makers lavished with subsidies
S&P 500   4,109.31
DOW   33,274.15
QQQ   320.93
MarketBeat Week in Review – 3/27 - 3/31
Modern Day Options Trading For Beginners! (Ad)pixel
UK travelers face hours-long waits for ferries to France
Intensity and insults rise as lawmakers debate debt ceiling
Modern Day Options Trading For Beginners! (Ad)pixel
Credit Suisse takeover hits heart of Swiss banking, identity
Small areas reopen near Fukushima nuclear plant, few return
Did You See These Trend Reversals? (Ad)pixel
UN food chief: Billions needed to avert unrest, starvation
'War of the states': EV, chip makers lavished with subsidies
S&P 500   4,109.31
DOW   33,274.15
QQQ   320.93
MarketBeat Week in Review – 3/27 - 3/31
Modern Day Options Trading For Beginners! (Ad)pixel
UK travelers face hours-long waits for ferries to France
Intensity and insults rise as lawmakers debate debt ceiling
Modern Day Options Trading For Beginners! (Ad)pixel
Credit Suisse takeover hits heart of Swiss banking, identity
Small areas reopen near Fukushima nuclear plant, few return
Did You See These Trend Reversals? (Ad)pixel
UN food chief: Billions needed to avert unrest, starvation
'War of the states': EV, chip makers lavished with subsidies
OTCMKTS:SARTF

Sartorius Aktiengesellschaft - SARTF Stock Forecast, Price & News

$332.50
0.00 (0.00%)
(As of 03/31/2023 12:00 AM ET)
Add
Compare
Today's Range
$332.50
▼
$332.50
50-Day Range
$329.50
▼
$395.00
52-Week Range
$267.00
▼
$405.00
Volume
N/A
Average Volume
2 shs
Market Capitalization
$11.38 billion
P/E Ratio
31.67
Dividend Yield
N/A
Price Target
$540.00

Sartorius Aktiengesellschaft MarketRank™ Forecast

Analyst Rating
Hold
2.40 Rating Score
Upside/​Downside
62.4% Upside
$540.00 Price Target
Short Interest
Healthy
0.00% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.89 out of 5 stars

See Top Rated MarketRank™ Stocks Here

SARTF stock logo

About Sartorius Aktiengesellschaft (OTCMKTS:SARTF) Stock

Sartorius AG engages in the provision of solutions for biopharmaceutical research. It operates through following divisions: Bioprocess Solutions (BPS), and Lab Products and Service (LPS). The Bioprocess Solutions division focuses on single-use solutions, helps customers manufacture biotech medications and vaccines safely and efficiently. The Lab Products and services division serves the needs of laboratories performing research and quality control at pharma and biopharma companies and those of academic research institutes. The company was founded by Florence Sartorius, Sr. in 1870 and is headquartered in Goettingen, Germany.

Receive SARTF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sartorius Aktiengesellschaft and its competitors with MarketBeat's FREE daily newsletter.

SARTF Stock News Headlines

March 31, 2023 | finanznachrichten.de
Aktien»Nachrichten»SARTORIUS AG VZ AKTIE»Sartorius Shareholders Approve All Proposals
August 8, 2022 | finance.yahoo.com
Sartorius to acquire Albumedix, strengthening its portfolio of innovative advanced therapy solutions
April 1, 2023 | Vantage Point (Ad)
Where Are The Markets Going Next?
More banking collapses could be imminent. If you have any money (at all) invested in the markets... even just your retirement... you'll want to see THIS. What we reveal now could help you sooner (and you won’t want it to be later). pixel
July 27, 2022 | seekingalpha.com
Sartorius Aktiengesellschaft (SARTF) Investor Presentation - Slideshow
July 23, 2022 | seekingalpha.com
Sartorius Aktiengesellschaft 2022 Q2 - Results - Earnings Call Presentation
March 25, 2022 | finance.yahoo.com
Resolutions of the Annual General Shareholders' Meeting of Sartorius AG
January 28, 2022 | markets.businessinsider.com
Sartorius closes fiscal 2021 with 50 percent growth and a jump in profitability
January 28, 2022 | seekingalpha.com
Sartorius Aktiengesellschaft GAAP EPS of €8.08, revenue of €3.45B
April 1, 2023 | Vantage Point (Ad)
What’s At Stake In April is Shocking
The Fed will be meeting on a topic that could change trading forever, and the decision could come as soon as the end of April. But by taking the smartest approach now, you can help shield your assets and work toward your trading goals. Time, as always, is of the essence. Click on this link to see what you need to do right away. pixel
December 16, 2021 | finance.yahoo.com
Sartorius strengthens its bioanalytics portfolio by acquiring a majority stake in ALS Automated Lab Solutions
October 21, 2021 | uk.finance.yahoo.com
Sartorius Aktiengesellschaft (SRT.DE)
September 30, 2021 | finance.yahoo.com
SARTORIUS AG (SARTF) Surges 3.7%: Is This an Indication of Further Gains?
September 16, 2021 | finance.yahoo.com
Sartorius to Open New Application and Service Hub in Shanghai
September 4, 2021 | finance.yahoo.com
Sartorius To Join The DAX Blue Chip Index
July 29, 2021 | finance.yahoo.com
Sartorius acquires cell culture specialist Xell AG
July 26, 2021 | finance.yahoo.com
Earnings Estimates Rising for SARTORIUS AG (SARTF): Will It Gain?
July 23, 2021 | finance.yahoo.com
What Makes SARTORIUS AG (SARTF) a New Buy Stock
July 21, 2021 | finance.yahoo.com
Sartorius continues on its fast growth trajectory - significant double-digit increases in sales and earnings
July 13, 2021 | finance.yahoo.com
SARTORIUS AG (SARTF) to Report Q2 Results: Wall Street Expects Earnings Growth
April 23, 2021 | seekingalpha.com
Sartorius Aktiengesellschaft 2021 Q1 - Results - Earnings Call Presentation
February 18, 2021 | finance.yahoo.com
Sartorius looks back on a very successful 2020 and expects further strong growth
November 2, 2020 | finance.yahoo.com
Sartorius closes acquisition of BIA Separations
October 20, 2020 | seekingalpha.com
Sartorius Aktiengesellschaft (SARTF) CEO Dr. Joachim Kreuzburg on Q3 2020 Results - Earnings Call Transcript
September 29, 2020 | seekingalpha.com
Repligen Continues To Gain Share In The Fast-Growing Bioproduction Market
October 22, 2019 | seekingalpha.com
Sartorius AG (SARTF) CEO Joachim Kreuzburg on Q3 2019 Results - Earnings Call Transcript
See More Headlines
Receive SARTF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sartorius Aktiengesellschaft and its competitors with MarketBeat's FREE daily newsletter.

SARTF Company Calendar

Last Earnings
2/17/2023
Today
4/01/2023
Fiscal Year End
12/31/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Dental equipment & supplies
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:SARTF
Previous Symbol
NASDAQ:SARTF
CUSIP
N/A
CIK
N/A
Web
www.sartorius.com
Phone
495513080
Fax
49-55-1308-3289
Employees
13,832
Year Founded
1870

Price Target and Rating

Average Stock Price Forecast
$540.00
High Stock Price Forecast
$540.00
Low Stock Price Forecast
$540.00
Forecasted Upside/Downside
+62.4%
Consensus Rating
Hold
Rating Score (0-4)
2.40
Research Coverage
5 Analysts

Profitability

EPS (Most Recent Fiscal Year)
$10.50
Trailing P/E Ratio
31.67
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$714.57 million
Net Margins
16.33%
Pretax Margin
24.43%
Return on Equity
29.14%
Return on Assets
10.14%

Debt

Debt-to-Equity Ratio
0.67
Current Ratio
0.96
Quick Ratio
0.43

Sales & Book Value

Annual Sales
$4.40 billion
Price / Sales
2.59
Cash Flow
$27.12 per share
Price / Cash Flow
12.26
Book Value
$59.46 per share
Price / Book
5.59

Miscellaneous

Outstanding Shares
34,230,000
Free Float
N/A
Market Cap
$11.38 billion
Optionable
Not Optionable
Beta
0.82

Social Links


Key Executives

  • Joachim Kreuzburg
    Chief Executive Officer
  • Volker Niebel
    Head-Production, Procurement & Business Operations
  • Rainer Lehmann
    Chief Financial Officer
  • Oscar-Werner Reif
    Head-Research & Development
  • Petra Kirchhoff
    Member-Supervisory Board & Head-IR

Key Competitors

View All Competitors













SARTF Stock - Frequently Asked Questions

Should I buy or sell Sartorius Aktiengesellschaft stock right now?

5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Sartorius Aktiengesellschaft in the last twelve months. There are currently 3 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" SARTF shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SARTF, but not buy additional shares or sell existing shares.
View SARTF analyst ratings or view top-rated stocks.

What is Sartorius Aktiengesellschaft's stock price forecast for 2023?

5 brokers have issued twelve-month target prices for Sartorius Aktiengesellschaft's shares. Their SARTF share price forecasts range from $540.00 to $540.00. On average, they expect the company's stock price to reach $540.00 in the next twelve months. This suggests a possible upside of 62.4% from the stock's current price.
View analysts price targets for SARTF or view top-rated stocks among Wall Street analysts.

How have SARTF shares performed in 2023?

Sartorius Aktiengesellschaft's stock was trading at $345.3030 at the beginning of the year. Since then, SARTF shares have decreased by 3.7% and is now trading at $332.5001.
View the best growth stocks for 2023 here.

How were Sartorius Aktiengesellschaft's earnings last quarter?

Sartorius Aktiengesellschaft (OTCMKTS:SARTF) released its quarterly earnings results on Friday, February, 17th. The company reported $2.30 earnings per share for the quarter, topping analysts' consensus estimates of $1.65 by $0.65. The firm earned $1.08 billion during the quarter, compared to analysts' expectations of $873.35 million. Sartorius Aktiengesellschaft had a trailing twelve-month return on equity of 29.14% and a net margin of 16.33%.

What is Sartorius Aktiengesellschaft's stock symbol?

Sartorius Aktiengesellschaft trades on the OTCMKTS under the ticker symbol "SARTF."

How do I buy shares of Sartorius Aktiengesellschaft?

Shares of SARTF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Sartorius Aktiengesellschaft's stock price today?

One share of SARTF stock can currently be purchased for approximately $332.50.

How much money does Sartorius Aktiengesellschaft make?

Sartorius Aktiengesellschaft (OTCMKTS:SARTF) has a market capitalization of $11.38 billion and generates $4.40 billion in revenue each year. The company earns $714.57 million in net income (profit) each year or $10.50 on an earnings per share basis.

How many employees does Sartorius Aktiengesellschaft have?

The company employs 13,832 workers across the globe.

Does Sartorius Aktiengesellschaft have any subsidiaries?
The following companies are subsidiares of Sartorius Aktiengesellschaft: ALS Automated Lab Solutions GmbH, BI Shanghai Co. Ltd., BIA Separations, Beit Haemek Import and Marketing Agricultural Cooperative Society Ltd., Biological Industries, Biological Industries Hong Kong Ltd., Biological Industries Israel Beit Haemek Ltd., Biological Industries USA Inc., CellGenix Inc., Cellca GmbH, Denver Instrument (Beijing) Co. Ltd., Essen BioScience, Essen BioScience K.K., Essen BioScience Ltd., Essen Instruments Inc., IntelliCyt Corporation, LLC Sartogosm, LLC Sartorius RUS, LLC Sartorius Stedim RUS, LabTwin GmbH, Life Science Factory Management GmbH, Life Science Factory gGmbH, MKS Instruments AB (Umetrics), Novasep’s chromatography division, SI Grone 1-Verwaltungs-GmbH, SI Weende-Verwaltungs-GmbH, SIV Grone 1 GmbH & Co. KG, SIV Grone 2 GmbH, SIV Weende GmbH & Co. KG, SWT Treuhand GmbH, Sartonets Taiwan Inc, Sartonets Taiwan Inc., Sartorius (Shanghai) Trading Co. Ltd., Sartorius AG, Sartorius Argentina S.A., Sartorius Australia Pty. Ltd., Sartorius Austria GmbH, Sartorius Belgium N.V., Sartorius Biohit Liquid Handling Oy, Sartorius Canada Inc., Sartorius Corporate Administration GmbH, Sartorius Corporation, Sartorius France S.A.S., Sartorius Hong Kong Ltd., Sartorius Hungária Kft., Sartorius India Pvt. Ltd., Sartorius Ireland Ltd., Sartorius Israel Ltd., Sartorius Italy S.r.l., Sartorius Japan K.K., Sartorius Korea Biotech Co. Ltd., Sartorius Korea Ltd., Sartorius Lab Holding GmbH, Sartorius Lab Instruments GmbH & Co. KG, Sartorius Malaysia Sdn. Bhd., Sartorius Netherlands B.V., Sartorius Nordic Oy, Sartorius North America Inc., Sartorius Peru S.A.C., Sartorius Poland Sp. z o.o., Sartorius Scientific Instruments (Beijing) Co. Ltd., Sartorius Singapore Pte. Ltd., Sartorius South Africa (Pty) Ltd., Sartorius Spain S.A., Sartorius Stedim (Shanghai) Trading Co. Ltd., Sartorius Stedim Aseptics S.A.S., Sartorius Stedim Australia Pty. Ltd., Sartorius Stedim Austria GmbH, Sartorius Stedim Belgium N.V., Sartorius Stedim BioOutsource Ltd., Sartorius Stedim Bioprocess S.A.R.L., Sartorius Stedim Biotech (Beijing) Co. Ltd., Sartorius Stedim Biotech GmbH, Sartorius Stedim Biotech S.A., Sartorius Stedim Cellca GmbH, Sartorius Stedim Data Analytics AB, Sartorius Stedim FMT S.A.S., Sartorius Stedim Filters Inc., Sartorius Stedim France S.A.S., Sartorius Stedim Hungária Kft., Sartorius Stedim India Pvt. Ltd., Sartorius Stedim Ireland Ltd., Sartorius Stedim Italy S.p.A., Sartorius Stedim Japan K.K., Sartorius Stedim Lab Ltd., Sartorius Stedim Malaysia Sdn. Bhd., Sartorius Stedim Netherlands B.V., Sartorius Stedim Nordic Oy, Sartorius Stedim North America Holding GmbH, Sartorius Stedim North America Inc., Sartorius Stedim Plastics GmbH, Sartorius Stedim Poland Sp. z o.o., Sartorius Stedim Singapore Pte. Ltd., Sartorius Stedim Spain S.A., Sartorius Stedim Switzerland AG, Sartorius Stedim Systems GmbH, Sartorius Stedim UK Ltd., Sartorius UK Ltd., Sartorius Ventures GmbH, Sartorius Vietnam Co. Ltd., Sartorius Weighing Technology GmbH, Sartorius de México S.A. de C.V., Sartorius do Brasil Ltda., TAP Biosystems (PHC) Ltd., TAP Biosystems Group Ltd., TAP Biosystems Ltd., TAP ESOP Management Ltd., The Automation Partnership Cambridge Ltd., ViroCyt Inc, WaterSep BioSeparations LLC, Xell AG, and kSep Holdings Inc..
Read More
How can I contact Sartorius Aktiengesellschaft?

Sartorius Aktiengesellschaft's mailing address is OTTO-BRENNER-STRASSE 20, GOETTINGEN 2M, 37079. The official website for the company is www.sartorius.com. The company can be reached via phone at 495513080, via email at ben.orzelek@sartorius.com, or via fax at 49-55-1308-3289.

This page (OTCMKTS:SARTF) was last updated on 4/1/2023 by MarketBeat.com Staff